On Thursday, 23 June, the AmCham EU Security, Defence and Space Committee and the Bureau of Industry and Security (BIS) at the US Department of Commerce co-hosted a webinar on US export controls. The discussion focussed on the role of the BIS in formulating US export controls policy, the US sanctions regime currently in place on Russia and Belarus as well as the cooperation that has taken place between the EU and US on export controls.
EU-US cooperation on export controls: a joint approach
On Thursday, 23 June, the AmCham EU Security, Defence and Space Committee and the Bureau of Industry and Security (BIS) at the US Department of Commerce co-hosted a webinar on US export controls. The discussion focussed on the role of the BIS in formulating US export controls policy, the US sanctions regime currently in place on Russia and Belarus as well as the cooperation that has taken place between the EU and US on export controls.
The webinar was presented by Eileen Albanese, Director of the Office of National Security and Technology Transfer Controls BIS; Matthew Borman, Deputy Assistant Secretary of Commerce for Export Administration, BIS; and Mike Lally, Minister Counselor for Commercial Affairs in Europe, US Mission.
Taking place primarily through the connections and dialogues previously established by the Trade and Technology Council in September 2021, unprecedented level of cooperation in this area between the EU and US is a prime example of the importance of close transatlantic relationships. In addition, the speed at which these export controls were agreed upon by the transatlantic partners and implemented sends a strong message regarding the strength of the EU-US bond and the value of cooperating with like-minded countries.
Related items
:focal())
Position Paper
13 May 2026
Strengthening Europe’s cybersecurity framework through simplification
The review of the Cybersecurity Act (CSA 2.0) is an opportunity to build a more coherent, outcome-oriented EU cybersecurity framework. While the proposal recognises fragmentation across the Single Market, further simplification is needed to reduce overlaps and support effective compliance.
A harmonised approach to risk assessment and supervision can strengthen resilience while avoiding duplicative obligations. Certification and supply-chain measures should remain risk-based, objective, technical and aligned with international standards. Structured industry engagement and clear designation thresholds under the ICT Supply Chain Framework and a secure-by-design approach to policymaking will be essential to support cybersecurity and global interoperability. Read more on how CSA 2.0 can strengthen resilience across the Single Market.
:focal())
News
4 May 2026
Discussing financial services with policymakers in Paris and Strasbourg
From Monday, 27 to Wednesday, 29 April, AmCham EU travelled to Paris, France and the European Parliament in Strasbourg, France for a series of meetings on EU financial services policy developments. The delegation engaged with representatives from French and European financial authorities, Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to share business perspectives on the EU’s financial services agenda. Discussions focused on how to improve Europe’s competitiveness, deepen capital markets and create the right conditions for innovation in digital finance. Members also highlighted the need for more coherent and interoperable rules that reduce complexity while encouraging long-term investment through risk-based regulation.
:focal())
News
4 May 2026
Discussing healthcare policy priorities in Strasbourg
On Tuesday, 28 to Wednesday, 29 April, AmCham EU travelled to the European Parliament in Strasbourg, France for a series of meetings with policymakers to discuss ongoing EU healthcare policy initiatives. The delegation met with Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to discuss priorities for the EU’s health agenda. This included exchanges on how to strengthen Europe’s life sciences competitiveness and support resilient supply chains. Members also stressed the need for urgent action to simplify overlapping rules and reduce complexity. They underlined that proportionate, risk-based regulation is essential to support innovation. This approach can also help ensure timely patient access to medicines, medical technologies and diagnostics.
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.